Drugs / approved Rabies vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT07500207 Comparator | Mar → May 2026 overdue | rabies | Changchun BCHT Biotechnology Co. | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | approved Rabies vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07500207 ↗ |
| Modality | Vaccine | “Lyophilized Rabies Vaccine” NCT07500207 ↗ |